Antagonistic analogs of luteinizing hormone-releasing hormone are mast cell secretagogues
- PMID: 2420726
- DOI: 10.1159/000234028
Antagonistic analogs of luteinizing hormone-releasing hormone are mast cell secretagogues
Abstract
The histamine-releasing activity of luteinizing hormone-releasing hormone (LHRH) antagonistic analogs has been documented. Antagonists of LHRH elicited in vitro histamine release from mast cells obtained from previously unexposed rats. Intradermal injection of the antagonists caused increased local skin permeability. Anaphylactoid reactions followed subcutaneous injection of the antagonists and in some cases these edematous reactions were accompanied by increased serum histamine levels. These studies show that these small peptides can cause mast cell degranulation and suggest that the neuropeptide, LHRH, may have modulating effects on the immune system.
Similar articles
-
Use of the cutaneous anaphylactoid test to detect differences in mast cell mediator-releasing activity among LHRH peptides.Int Arch Allergy Appl Immunol. 1987;84(3):316-20. doi: 10.1159/000234441. Int Arch Allergy Appl Immunol. 1987. PMID: 2443460
-
Antagonists of luteinizing hormone releasing hormone bind to rat mast cells and induce histamine release.Agents Actions. 1988 Dec;25(3-4):307-13. doi: 10.1007/BF01965036. Agents Actions. 1988. PMID: 2464275
-
Acute stress results in skin corticotropin-releasing hormone secretion, mast cell activation and vascular permeability, an effect mimicked by intradermal corticotropin-releasing hormone and inhibited by histamine-1 receptor antagonists.Int Arch Allergy Immunol. 2003 Mar;130(3):224-31. doi: 10.1159/000069516. Int Arch Allergy Immunol. 2003. PMID: 12660427
-
[Changes in degranulation and histamine release from mast cells in rats sensitized by penicilloyl-protein].Zhongguo Yao Li Xue Bao. 1989 Jan;10(1):78-81. Zhongguo Yao Li Xue Bao. 1989. PMID: 2479221 Chinese.
-
Development and applications of luteinizing hormone-releasing hormone antagonists in the treatment of infertility: an overview.Hum Reprod. 1995 Aug;10(8):1974-81. doi: 10.1093/oxfordjournals.humrep.a136219. Hum Reprod. 1995. PMID: 8567825 Review.
Cited by
-
The structural features of effective antagonists of the luteinizing hormone releasing hormone.Amino Acids. 1994 Jun;6(2):111-30. doi: 10.1007/BF00805840. Amino Acids. 1994. PMID: 24190782
-
Study of the activation mechanism of human GRF(1-29)NH2 on rat mast cell histamine release.Inflamm Res. 1995 Feb;44(2):87-91. doi: 10.1007/BF01793219. Inflamm Res. 1995. PMID: 7544679
-
Highly potent antagonists of luteinizing hormone-releasing hormone free of edematogenic effects.Proc Natl Acad Sci U S A. 1988 Mar;85(5):1637-41. doi: 10.1073/pnas.85.5.1637. Proc Natl Acad Sci U S A. 1988. PMID: 3278323 Free PMC article.
-
Inhibition of growth of human mammary tumor cells by potent antagonists of luteinizing hormone-releasing hormone.Proc Natl Acad Sci U S A. 1989 Mar;86(5):1648-51. doi: 10.1073/pnas.86.5.1648. Proc Natl Acad Sci U S A. 1989. PMID: 2646641 Free PMC article.
-
Degarelix, a novel GnRH antagonist, causes minimal histamine release compared with cetrorelix, abarelix and ganirelix in an ex vivo model of human skin samples.Br J Clin Pharmacol. 2010 Oct;70(4):580-7. doi: 10.1111/j.1365-2125.2010.03730.x. Br J Clin Pharmacol. 2010. PMID: 20840449 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources